The molecule, EdU, mimics thymine in DNA, replacing it and acting as a tracker, UNC Health said Aug. 23. It could be the basis for an effective brain cancer treatment, since it triggers a runaway DNA repair process in cells that are actively dividing.
Most healthy cells in the brain are nondividing, while cancerous cells divide rapidly.
“We want to stress that this is a basic but important scientific discovery,” said study senior author Aziz Sancar, MD, PhD. “The scientific community has much work ahead to figure out if EdU could actually become a weapon against cancer.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
